3 Results for "

G719X

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "G719X" in MCE Product Catalog:

9
9 Cited Publications
Cat. No.: HY-112823
CAS No.: 1899921-05-1
Purity:  99.83%
Synonyms: HS-10296
Target:  

EGFR

Research Areas:  

Cancer

Almonertinib (HS-10296) is an orally available, irreversible, third-generation EGFR tyrosine kinase inhibitor with high selectivity for EGFR-sensitizing and T790M resistance mutations. Almonertinib shows great inhibitory activity against T790M, T790M/L858R and T790M/Del19 (IC50: 0.37, 0.29 and 0.21 nM, respectively), and is less effective against wild type (3.39 nM). Almonertinib is used for the research of the non-small cell lung cancer .
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-112823B
CAS No.: 2134096-03-8
Purity:  99.77%
Synonyms: HS-10296 hydrochloride
Target:  

EGFR

Research Areas:  

Cancer

Almonertinib (HS-10296) hydrochloride is an orally available, irreversible, third-generation EGFR tyrosine kinase inhibitor with high selectivity for EGFR-sensitizing and T790M resistance mutations. Almonertinib hydrochloride shows great inhibitory activity against T790M, T790M/L858R and T790M/Del19 (IC50: 0.37, 0.29 and 0.21 nM, respectively), and is less effective against wild type (3.39 nM). Almonertinib hydrochloride is used for the research of the non-small cell lung cancer .
loading...
    loading...
Cat. No.: HY-112823R
CAS No.: 1899921-05-1
Synonyms: HS-10296 (Standard)
Research Areas:  

Cancer

Almonertinib (Standard) is the analytical standard of Almonertinib. This product is intended for research and analytical applications. Almonertinib (HS-10296) is an orally available, irreversible, third-generation EGFR tyrosine kinase inhibitor with high selectivity for EGFR-sensitizing and T790M resistance mutations. Almonertinib shows great inhibitory activity against T790M, T790M/L858R and T790M/Del19 (IC50: 0.37, 0.29 and 0.21 nM, respectively), and is less effective against wild type (3.39 nM). Almonertinib is used for the research of the non-small cell lung cancer .
loading...
    loading...